Who has invested in PathAI?

General Catalyst, General Atlantic, D1 Capital Partners are named among the investors backing PathAI.

PathAI Funding: $255M Raised, Series C (2023)

PathAI funding overview

PathAI is a Healthtech company based in Boston, MA. PathAI has raised $255M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in July 2023. The round record for PathAI runs through 2023; nothing later has been disclosed. Investors on record include General Catalyst, General Atlantic, D1 Capital Partners. 3 distinct backers are named across the disclosed rounds.

PathAI at a glance

Total raised: $255M
Latest round: Series C
Latest round date: July 2023
Industry: Healthtech
Headquarters: Boston, MA
Notable investors: General Catalyst, General Atlantic, D1 Capital Partners

Frequently asked about PathAI funding

How much has PathAI raised?: PathAI has raised $255M in total disclosed funding across the rounds on record.
Who has invested in PathAI?: General Catalyst, General Atlantic, D1 Capital Partners are named among the investors backing PathAI.
What was the latest PathAI funding round?: The most recent disclosed round is a Series C, announced in July 2023.
Where is PathAI based?: PathAI is based in Boston, MA.
What sector does PathAI operate in?: PathAI is tracked under Healthtech from Boston, MA, with $255M in disclosed funding.
When did PathAI last raise?: The last disclosed PathAI round closed in July 2023 at Series C.

We update the PathAI record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Healthtech companies in Boston and their backers are listed below.

PathAI Funding: $255M Raised, Series C (2023)

PathAI funding overview

PathAI at a glance

Frequently asked about PathAI funding

PathAI founders (1)

Companies related to PathAI (40)

Browse related funding lists (8)